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Previous studies have shown that thrombospondin (TSP) is an adhesion factor 
for some human tumor cells. The  previous studies have shown further that tumor 
cells which utilize TSP  as an adhesion factor also synthesize it. This study 
continues the effort to understand how TSP  production and expression are 
regulated in human tumor cells and the consequences of this for the cells. It is 
shown that differences among cell lines in their capacity to biosynthesize TSP  are 
associated with differences in T S P  specific m R N A  levels. This indicates that 
biosynthesis is regulated at the transcriptional level. There is also a direct 
relationship between TSP  biosynthesis and secretion into the culture medium 
and expression at the cell surface. The cells which are the most biosynthetically 
active secrete amounts of TSP  into the culture medium that are sufficient to elicit 
a detectable response in the cell-substrate adhesion assay. The  kinetics of TSP  
secretion by these cells are in accord with the kinetics of attachment and spreading 
of the same cells in the absence of exogenous adhesion factors. These data are 
consistent with the idea that endogenously produced TSP  promotes the adhesion 
of the cells which synthesize it in an autocrine manner. 
I n t r o d u c t i o n  
T h r o m b o s p o n d i n  ( T S P )  is syn thes i zed  by  a va r ie ty  of  d i f ferent  cell  t ypes  and  
i n c o r p o r a t e d  into the  ex t race l lu la r  m a t r i x  ( E C M )  of  these  cells [11, 15, 16, 19, 24, 
31]. L ike  o the r  c o m p o n e n t s  of  the  E C M ,  T S P  s t imula te s  cell  a t t a c h m e n t  and  
sp read ing  [21, 27, 29-31 ]. S tud ie s  in our  l a b o r a t o r y  have focused  on the  role of  T SP 
in h u m a n  t u m o r  cell  b io logy .  O u r  s tud ies  have shown  tha t  ce r ta in  t u m o r  cell  l ines 
syn thes ize  T S P  [29] and  c o n c o m i t a n t l y  express  surface  b i n d i n g  sites for  T S P  [20]. 
T h e  p r o d u c t i o n  of  bo th  the  l igand  and  its r e c e p t o r  b y  the same cell  p rov ides  a 
m e c h a n i s m  w h e r e b y  the l igand  cou ld  be  used  as an e n d o g e n o u s  a d h e s i o n  factor .  
T h i s  s t u d y  charac te r izes  T S P  p r o d u c t i o n  in a n u m b e r  of  h u m a n  t u m o r  cell  l ines 
de r ived  f rom s q u a m o u s  ca rc inomas ,  m e l a n o m a s  and  g l iomas .  I t  is shown  tha t  the re  
is a d i rec t  r e l a t ionsh ip  be tween  T S P  b iosyn thes i s  and  the a m o u n t  of  T S P - s p e c i f i c  
m R N A  in the  cells,  sugges t ing  tha t  b io syn thes i s  is r egu la t ed  at the  t r a n s c r i p t i o n a l  
level.  T h e r e  is, in add i t ion ,  a d i rec t  r e l a t ionsh ip  b e t w e e n  T S P  b io syn the s i s  and  
secre t ion  into the  cu l tu re  m e d i u m  and  cell  surface  express ion .  T h e  cells wh ich  are 
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the most  biosynthetically active (squamous carcinoma) produce amounts  of T S P  
that are sufficient to elicit a cell-substrate adhesion response. Taken  together, these 
results support  the idea that endogenously synthesized T S P  may promote  tumor  cell 
adhesion in an autocrine type of manner.  
Materials  and m e t h o d s  
Cells 
A number  of human  squamous carcinoma, melanoma and glioma lines were 
used. The  isolation and characterization of these lines have been described 
previously [2, 12, 14]. These  lines were used in our recent studies characterizing the 
cell-substrate adhesion response to T S P  [29, 30]. T S P  binding studies have also 
been conducted using some of the same cell lines. These  studies showed a direct 
correlation between T S P  binding and TSP- induced  cell-substrate adhesion [20]. 
For  this study, all of the lines were grown in monolayer  culture under  identical 
conditions. The  growth med ium was minimal essential med ium of Eagle and Earle 's  
salts (MEM)  supplemented with non-essential amino acids, 15 per cent fetal bovine 
serum, 100 U/ml  of penicillin and 100/~g/ml of s treptomycin.  Growth  was at 37~ in 
med ium equilibrated with 5 per cent CO 2. The  cells were subcultured by 
trypsinization as required. 
Reagents 
T S P  was purified f rom the supernatant  fluid of thrombin-act ivated platelets as 
described previously [4]. The  purifies T S P  migrated as a single protein band with an 
apparent  M r of 180 kD when examined by sodium dodecylsulfate-polyacrylamide 
gel electrophoresis ( S D S - P A G E )  under reducing conditions. 
Rabbit  polyclonal antibodies to T S P  and three different monoclonal  antibodies 
to T S P  were used. The  three monoclonal antibodies used were antibody A2.5, 
directed against the heparin-binding domain of the T S P  molecule; ant ibody A6.1, 
directed against an epitope located within the 70-kD trypsin-resistant  core of the 
T S P  molecule; and antibody A4.1, directed at an epitope within a 45-kD fragment  
that is itself within the 70-kD trypsin-resistant  core. The  product ion and character- 
izat ion of the polyclonal and monoclonal  antibodies have been described previously 
[5-7, 10, 31]. The  monoclonal antibodies were purified f rom ascites fluid by 
ammon ium sulfate precipitation followed by affinity chromatography  on protein A- 
Sepharose. Purity was determined by S D S - P A G E .  T h e  rabbit  polyclonal ant ibody 
against T S P  was purified by affinity chromatography on protein A-Sepharose .  
Specificity for T S P  was confirmed by solid-phase radioimmunoassay performed 
with immobil ized antibodies and T S P  iodinated with Na125I and iodobeads. 
Biosynthetic labeling 
The  cells were grown in 100-mm (diameter) culture dishes to an approximate  
density of 1 x 107 cells per dish. The  cells were washed and incubated for 30 min in 
methionine-free,  serum-free minimal  essential med ium (Flow Laboratories,  
McLean,  VA) followed by a 60-rain incubation in the same med ium supplemented 
with 100#Ci per dish of [35S]methionine (1000-1400/~Ci/#mole) (NEN,  Boston, 
MA). After the 60-rain biosynthetic pulse, the cells were again washed and incubated 
for a further  4 h in complete medium.  The  4-h chase cells were lysed in a solution of 
phosphate-buffered saline (PBS) containing three detergents (1 per cent Tr i ton  X- 
100, 0"5 per cent sodium deoxycholate and 0"1 per cent SDS; all obtained from 
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Sigma) and protease inhibitors including 20 m M  E D T A ,  5 m M  N-ethylmale imide ,  
2 m M  phenylmethylsulfonyl  fluoride (PMSF)  and 10 pl/10 ml o fa  protease inhibitor 
cocktail containing leupeptin 1 mg/ml,  antipain 1 mg/ml ,  benzamidine 10mg/ml ,  
aprotinin 10 000 kallikrein-inactivating units/ml,  chymostat in  1 mg/ml  and pepstat-  
in 1 ml/ml,  as described by Ronnet t  et al. [22] in studies on the insulin receptor. All of 
the protease inhibitors were obtained f rom Sigma. The  4-h chase media were also 
supplemented with the detergent/protease inhibitor mixture  by adding a one- 
quarter volume of a 5-fold concentrated solution. The  cell lysates and chase media 
were frozen at - 8 0 ~  thawed and clarified by ultracentrifugation (37000g for 
60 min). Immunoreac t ive  T S P  was precipitated with a 1 : 100 dilution of the rabbit  
an t i -TSP  and protein A-Sepharose  (Sigma) according to the protocol of Ruddon 
et al. [23]. Normal  rabbit  serum served as a control. T h e  washed immunoprec ip -  
itates were divided in half and eluted with boiling (5 min) in 2-fold concentrated 
Laemmli  S D S - P A G E  sample buffer [13], either with or without  2 per cent 2- 
mercaptoethanol .  The  immunoprecipi ta ted  material was fractionated on a 3-10 per 
cent polyacrylamide gel employing the Laemml i  system. Radioactive bands were 
visualized by autoradiography with En3Hance (NEN),  exposing the dried gels to X-  
ray film (Kodak XAR-2)  for 2 days. 
Preparation of R N A  and Northern blot analysis 
Total  R N A  for Nor thern  blot analysis was prepared f rom the cells using the 
method of Chirgwin et al. [3]. Typically,  yields f rom one 150-cm 2 flask were between 
100 and 200 #g of total RNA. 
For Nor thern  blot analysis, total R N A  samples and an R N A  ladder (Bethesda 
Research Laboratories),  which served as a molecular weight marker ,  were electro- 
phoresed through an agarose gel formed in 2"2M f o r m a l d e h y d e - 2 0 m M  3-(N- 
morpholino)propanesulfonic acid (MOPS)  buffer, p H  7"25, 0"1 m M  sodium acetate, 
and transferred directly into nitrocellulose in 3 M sodium chlor ide~-3  M sodium 
citrate as described by Thom as  [26]. The  filters were baked in vacuo at 80~ for 2 h 
and pre-hybridized in 40 per cent fo rmamide-0"6M sodium c h l o r i d e - 6 0 m M  
sodium citrate 5 x Denhard t ' s  solution (1 x Denhard t ' s  solut ion=0"02 per  cent 
bovine serum albumin-0"02 per cent Ficoll-0"02 per cent polyvinylpyrrol idone)-  
herring sperm D N A  [100 m g / m l ~ ' l  per cent sodium dodecylsulfate (SDS)-0"2 per 
cent sodium pyrophosphate-poly(A)  (1 #g/ml)] at 42~ for at least 3 h. Filters were 
washed in two changes of 0"3 M sodium chloride-30 m M  sodium citrate-0"l per  cent 
SDS at 25~ for 10min and two changes of 7 5 m M  sodium chlor ide-7"5mM 
sodium citrate-0"l per cent SDS at 50~ for 1 h each. T h e  filters were exposed to 
Kodak  XAR-5 film with Dupon t  Cronix intensifying screens at - 7 0 ~  A c D N A  
probe consisting of the heparin-binding domain of the T S P  molecule [8] was labeled 
with [a2p]dATP to a specific activity of 2-5 x 10  6 dpm/ng  by oligo-labeling [9] and 
used to identify TSP-specif ic  m R N A .  
Enzyme-linked immunosorbent assay ( E L I S A )  
E L I S A s  were performed to quantify the amount  of T S P  secreted into the culture 
med ium by the cells. Cells were plated at 3"5 x 105 cells per well in growth med ium 
and grown for 1 day. Following this, the cells were washed twice in serum-free  M E M  
and incubated for an additional 2 or 6 h in M E M  supplemented  with 200 #g/ml  of 
bovine serum albumin. The  culture med ium was then harvested, clarified by low- 
speed centrifugation and added to wells of a 96-well plate (Falcon Plastics, Oxnard,  
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CA) from lots that had been pre-screened for acceptability in ELISAs.  We used 
200#1 per well and incubated the wells for 4 h  at 37~ Serum-free M E M  
supplemented with 200 #g of bovine serum albumin served as the negative control. 
Purified human platelet T S P  (0"5-0"0005/~g per well) was also added to the assay 
plate in the same buffer to serve as a standard. After the 4-h incubation, the culture 
medium from the cells and the control culture medium were removed from the wells 
and the E L I S A  was then run exactly as described previously [28]. The cells from 
which the culture medium was obtained were harvested with trypsin and counted. 
Immunofluorescence 
The tumor cells were examined for an t i -TSP binding by indirect immuno- 
fluorescence 1 day after plating. For this, 2 x 105 cells from each line were seeded on 
to 20 x 20 mm glass cover-slips. The culture medium consisted of M E M  supplem- 
ented with 10 per cent fetal bovine serum. At the time of staining, the culture 
medium was removed and the cells were gently washed three times in cold PBS. All 
subsequent steps were carried out at 4~ The  cells were stained initially with a 1 : 20 
dilution of the rabbit an t i -TSP or normal rabbit serum (45 rain) and then washed 
three times. They  were then stained with a 1 : 50 dilution of fluorescein-conjugated 
swine anti-rabbit serum (45 min) obtained from Accurate Scientific and Chemical 
(Westbury, NY). Following three additional rinses in PBS, the cover-slips were 
placed on glass slides and viewed immediately by standard fluorescence microscopic 
techniques. Staining of the UM-SCC-11  B cells with the monoclonal antibodies was 
carried out using the same protocol, but in this case the secondary stain consisted of 
fluorescein-conjugated goat anti-mouse serum (Accurate Scientific and Chemical). 
Results  
TSP secretion 
ELISAs  were carried out to determine the amount of T S P  secreted into the 
culture medium by the tumor cell lines. For these studies, culture fluids from the cell 
lines were harvested after 2 h of incubation (unless indicated otherwise) and analysed 
for immunoreactive T S P  as described under Materials and methods. The  results of 
this study (table 1) indicated that the squamous carcinoma cells secreted significantly 
more T S P  into the culture fluid than the melanoma or glioma cells. The  results 
further showed that there was considerable variability among the squamous 
carcinoma lines. The most active squamous carcinoma cells (UM-SCC-11A)  
secreted 2-3 times more T S P  than the least active squamous carcinoma line (UM- 
SCC-22B) and approximately 20 times more than the least active melanoma line 
(SK-MEL-28) .  
Cell surface TSP expression 
Immunofluorescence studies were carried out to compare cell surface expression 
of T S P  by the tumor cell lines. The cells were grown on glass cover-slips for 1 day 
and then stained in the viable state with rabbit polyclonal ant i-TSP.  In parallel with 
what was seen in ELISAs ,  the squamous carcinoma cells exhibited more surface 
staining with ant i -TSP than did the melanoma or glioma cells. There was, 
furthermore, significant variability among the squamous carcinoma lines. For 
example, when examined by fluorescence microscopy and simultaneously by phase- 
contrast microscopy, it could be seen that more than 95 per cent of the U M - S C C -  
11B cells stained with the rabbit polyclonal ant i -TSP.  Punctate staining distributed 
Table 1. 
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I m m u n o r e a c t i v e  TSP in the cu l ture  f luid of  s q u a m o u s  c a r c i n o m a ,  
m e l a n o m a  and g l i o m a  ce l l s  ~ 
TSP 
Cell type (ng/lO 6 cells) 
Squamous carcinoma 
UM-SCC-1  95 + 5 
UM-SCC-11A 285 + 35 
U M - S C C -  11B 210 + 27 
UM-SCC-12  110+10 
UM-SCC-22B 90+ 15 
UM-SCC-11B (6h) 710+14 
UM-SCC-22B (6h) 120+10 
Melanoma 
U M - M E L - 1  25+5  
SK-MEL-10  15+ 1 
SK-MEL-27  85 + 10 
SK-MEL-28  10 + 2 
Glioma 
UM6 15 + 5 
U138 75+15 
a The buffer consisted of 200/~1 of M E M  supplemented with 200pg of bovine serum 
albumin per ml. Human platelet T S P  was added to the same buffer to generate a standard 
curve. The culture fluids consisted of the same buffer incubated for 2 or 6 h in the presence of 
3'5 x 105 cells. The  values represent ng of TSP  per ml per 1 x 106 cells. They were obtained 
directly from the standard curve generated with human platelet TSP.  All values are averages 
of duplicate wells in a single experiment_+ the differences between the individual values and 
the averages. The experiment was repeated three times with similar results. 
over  the  ent i re  surface  of  the  cells was seen. In  cont ras t ,  a m u c h  smal le r  p r o p o r t i o n  of  
the  U M - S C C - 2 2 B  cells ( a p p r o x i m a t e l y  5 pe r  cent)  showed  s ignif icant  s t a in ing  wi th  
the  same an t ibody .  T h e  r e m a i n d e r  of  the  U M - S C C - 2 2 B  cells showed  a ve ry  weak  
s ta in ing  pa t t e rn .  T h e  U M - S C C - 1 1 A  cells were  s imi la r  to U M - S C C - 1 1 B  whereas  
the  o the r  two s q u a m o u s  l ines were  i n t e r m e d i a t e  be tw e e n  U M - S C C - 1 1 B  and  U M -  
S C C - 2 2 B .  A m o n g  the m e l a n o m a  lines,  U M - M E L - 1  and  S K - M E L - 2 7  s h o w e d  
m o r e  s ta in ing  than  S K - M E L - 1 0  and  S K - M E L - 2 8 .  Of  the  two g l ioma  l ines,  U138  
showed  m o r e  s ta in ing  than  U M 6 .  T h e r e  was,  there fore ,  a good  co r re l a t ion  a m o n g  all 
of  the  cell l ines be tween  a m o u n t  of  T S P  secre ted  as i nd i ca t ed  by  E L I S A  and  the  
degree  of  cell surface  s ta in ing.  N o n e  of  the  cell  l ines  showed  v is ib le  s ta in ing  w h e n  
n o r m a l  r abb i t  s e r u m  was used  in p lace  of  a n t i - T S P .  S t a in ing  p a t t e r n s  seen w i th  
U M - S C C - 1 1 B ,  U M - S C C - 2 2 B  and  S K - M E L - 2 8  are shown  in f igure 1. 
T h e  U M - S C C - 1 1 B  cells were  also s t a ined  wi th  th ree  m o u s e  m o n o c l o n a l  
an t ibod ie s  agains t  T S P .  T h e s e  were  a n t i b o d y  A2.5,  d i r e c t e d  agains t  the  h e p a r i n -  
b i n d i n g  d o m a i n  of  the  T S P  molecule ;  a n t i b o d y  A6.1,  wh ich  b i n d s  to the  7 0 - k D  
t r y p s i n - r e s i s t a n t  core reg ion  of  the  T S P  molecu le ;  and  a n t i b o d y  A4.1,  wh ich  b i n d s  
to a 4 5 - k D  reg ion  wi th in  the  7 0 - k D  t r y p s i n - r e s i s t a n t  core  [5-7,  10, 31]. T h e  s ta in ing  
pa t t e rn  seen wi th  A2.5 was ve ry  s imi la r  to tha t  seen wi th  the  r abb i t  po lyc lona l  
an t ibody ,  tha t  is, a h igh  pe rcen tage  of  the  cells s t a ined  in the  v iab le  s ta te  and  the  
s ta in ing  a p p e a r e d  u n i f o r m l y  d i s t r i b u t e d  over  the  en t i re  cell surface  (figure 2). I n  
cont ras t ,  s ta in ing  wi th  a n t i b o d y  A6.1 was s imi la r  in p a t t e r n  b u t  weaker  (not  shown)  
and no s ta in ing  was seen wi th  a n t i b o d y  A4.1 (f igure 2). 
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F igure  1. Immunof luo re scence  s ta in ing  of cells in the  viable state. Cells g rown  on cover-  
slips for 1 day were gent ly  washed  in PBS  and  t hen  s ta ined at 4~ wi th  a 1 : 20 d i lu t ion  of 
r abb i t  polyclonal  a n t i - T S P  followed by  a 1 : 50 d i lu t ion  of  f luorescein isothiocyanate  
con juga ted  swine an t i - r abb i t  IgC. Pho tog rap h s  are 1 -min  exposures ,  • 800. (A) U M -  
SCC-11B;  (B) U M - S C C - 2 2 B ;  (C) S K - M E L - 2 8 .  
F igure  2. Immunof luo re scence  s ta in ing  of cells in the  viable state. U M - S C C - 1 1 B  cells 
g rown  on cover-s l ips  for 1 day were gent ly  washed  in PBS and  t hen  s ta ined at 4~ wi th  a 
1 : 20 d i lu t ion  of monoc lona l  an t ibodies  A2.5 and  A4.1 followed by a 1 : 50 d i lu t ion  of 
f luorescein isothiocyanate  con juga ted  goat  an t i -mouse  serum.  Ph o t o g rap h s  are l - r a i n  
exposures ,  • 800. (A) A2.5; (B) A4.1. 
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TSP biosynthesis 
In order to characterize the differences among the cell lines in T S P  production 
more fully, three of the cell lines, UM-SCC-11B,  UM-SCC-22B and SK-MEL-28 ,  
were examined for T S P  biosynthesis and for production of TSP-specific mRNA.  To  
measure biosynthesis, [35S]methionine was incorporated into the cells using a 1-h 
pulse/4-h chase protocol. Detergent lysates from the cells were then examined for 
[35 S]methionine incorporation into forms that were immunoprecipitable with rabbit 
mono-specific antibodies to TSP.  Under  the conditions of the experiment, all three 
lines incorporated similar amounts of [35S]methionine into trichloroacetic acid 
(TCA)-precipitable material. The  amount of incorporated methionine that was 
precipitable with antibodies to T S P  varied greatly, however, with the cell type. 
Autoradiograms of the immunoprecipitated material after separation by SDS-  
P A G E  under non-reducing conditions (figure 3) revealed that the U M - S C C - 1 1 B  
cells synthesized more T S P  than the UM-SCC-22B cells. Under  the same 
conditions, no detectable T S P  synthesis was observed with the S K - M E L - 2 8  cells. 
Similar differences between the three lines were also apparent on reduced gels (not 
shown). In order to quantitate the differences which were apparent from the 
autoradiograms, the radioactivity immunoprecipitated from cell extracts of each line 
was compared with the amount of radioactivity incorporated into TCA-precipitable 
material. With the UM-SCC-11B cells, approximately 0-09 per cent of the T C A -  
Figure 3. Immunoprecipitation of cell extracts from biosynthetically labeled UM-SCC- 
11B, UM-SCC-22B and SK-MEL-28 cell.s. The cells were labeled using a 1 -h pulse/4- 
h chase protocol and immunoprecipitated with polyclonal antibodies to TSP or normal 
rabbit serum. After solubilization, the immunoprecipitated material was separated on a 
3-10 per cent gradient of SDS-PAGE under non-reducing conditions and examined by 
autoradiography. Left, UM-SCC-11B cells; center, SK-MEL-28 cells; right, UM- 
SCC-22B cells. Lanes A, C and E contains anti-thrombospondin immunoprecipitates. 
Lanes B, D and F contain normal rabbit serum precipitates. 
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precipitable material was precipitated with the ant i -TSP antibodies. Less than 0"01 
per cent was immunoprecipitated from the UM-SCC-22B cells and there was no 
quantifiable material immunoprecipitated from the S K - M E L - 2 8  cells. 
In addition to the cell lysates, the culture fluids from the 1 -h pulse/4-h chase cells 
were examined for anti-TSP-precipitable material. Analysis of the culture fluids 
indicated that there was a direct relationship between the amount  of immunoreactive 
T S P  synthesized and the amount secreted (or shed) into the culture fluid. 
Approximately 2"5 per cent of the TCA-precipitable radioactivity in the cultiare fluid 
from the UM-SCC-11B cells was immunoprecipitated with antibodies to TSP.  
Only 0"4 per cent of the TCA-precipitable material in the culture fluid from the U M -  
SCC-22B cells was immunoprecipitated under the same conditions and no anti- 
TSP-precipitable material was detected in the culture fluid from the S K - M E L - 2 8  
cells. 
Northern blot analysis. Northern blot analysis was used to determine if the 
differences in T S P  biosynthesis between the three lines were due to alterations in the 
level of m R N A  for TSP.  A c D N A  probe consisting of the heparin-binding domain 
of the T S P  molecule [8] was used. Figure 4 shows an autoradiogram of the RNA blot 
prepared with two different concentrations of RNA (4 #g per lane in A, B and C and 
15 #g per lane in D, E and F). When 15 #g of RNA were loaded on to the gel, m R N A  
could be detected from both squamous carcinoma lines (lanes E and F) ,  but the 
signal was stronger with the U M - S C C - 1 1 B  cells (lane F) than with the U M - S C C -  
22B cells (lane E). No message was detected with the S K - M E L - 2 8  cells (lane D). 
Figure 4. Northern blot analysis of RNA isolated from SK-MEL-28 cells (lanes A and D), 
UM-SCC-22B cells (lanes B and E) and UM-SCC-11B cells (lanes C and F). Total 
RNA (4 #g in lanes A-C and 15 # g  in lanes D-F) was fractionated on a 1'4 per cent 
formaldehyde agarose gel and transferred to a nitrocellulose membrane. The thrombo- 
spondin transcript was detected by hybridization with a 32p-labeled 1"2 kb thrombo- 
spondin probe and autoradiography. 
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When 4#g  of RNA were loaded on to the gel, m R N A  was detected only with the 
U M - S C C - 1 1 B  cells (lane C). Hence there was a direct relationship between the 
amount  of T S P  m R N A  detected and the amount  of T S P  synthesized, indicating that 
T S P  biosynthesis was regulated at the transcriptional level. 
Discuss ion  
T S P  serves as an adhesion factor for a number  of different types of cells [21, 27, 
29-31]. Studies in our laboratory have shown that among human  tumor  cells, 
squamous carcinoma cells tend to be highly responsive to T S P  whereas melanoma 
cells and glioma cells are less responsive or non-responsive under  the same 
conditions [29, 30]. Additionally, our studies have shown that tumor  cells which 
respond to T S P  also synthesize the molecule [29]. These  cells simultaneously 
express receptors for T S P  on their surface [20], thus providing a mechanism 
whereby the endogenously synthesized protein could be used to promote  adhesion. 
This  study is a continuation of our efforts to characterize the product ion of T S P  by 
human tumor  cells and the possible role of the endogenously synthesized protein in 
cell-substrate adhesion. 
Here  it is shown that levels of T S P  m R N A  in three cell lines correlate closely with 
levels of T S P  synthesized by the same cells. Thus ,  T S P  product ion appears to be 
regulated at the transcriptional level. T h e  endogenously produced T S P  is secreted 
into the culture med ium and bound to the cell surface. There  is a direct relationship 
between the amount  of T S P  biosynthesized and the amount  secreted into the culture 
med ium and bound to the cell surface. Taken  together, these data indicate that 
several parameters  related to T S P  metabol ism vary together. Further ,  when the 
results of this study are compared with our previous results on measuring cell-  
substrate adhesion by the same cells [29, 30], they show that there is a good 
correlation between T S P  product ion and responsiveness to T S P  in the adhesion 
assay. This  supports  the suggestion that endogenously synthesized T S P  may be used 
by the cells which synthesize it to promote  cel l-substrate  adhesion. Our  previous 
finding that adhesion of U M - S C C - 1 1 B  cells to bovine serum albumin-coated dishes 
(i.e. in the absence of exogenous adhesion factors) could be blocked with polyclonal 
antibodies to T S P  [29] is consistent with this view. The  findings in this study that the 
most  responsive squamous carcinoma cells secrete amounts  of T S P  into the culture 
med ium that are sufficient to elicit a t tachment  and spreading [20, 29] and that the 
kinetics of T S P  secretion parallel closely the kinetics of a t tachment  and spreading on 
bovine serum albumin-coated dishes [20, 29] also support  this suggestion. 
Although these data suggest that T S P  synthesized by the squamous carcinoma 
cells can bind to receptors on the same cells and induce cel l-substrate  adhesion, little 
is known about the nature of the receptors or how the ligand actually interacts with 
the cells. Studies by Asch et al. [1] have suggested that the antigen which reacts with 
the O K M 5  monoclonal ant ibody serves as a T S P  receptor on some cells. Others have 
suggested that cell-surface heparan sulfate proteoglycans are responsible for T S P  
binding [17, 18]. In our studies with squamous carcinoma cells, we have been unable 
to demonstrate  inhibition of T S P  binding (unpublished observation) or T S P -  
induced at tachment  and spreading with O K M 5  ant ibody [31]. On the other hand, a 
monoclonal antibody directed against the hepar in-binding domain of T S P  (e.g. 
antibody A2.5) was shown in our previous studies partially to inhibit a t tachment  and 
spreading of squamous carcinoma cells on bovine serum albumin-coated dishes. 
This  antibody was not able to block at tachment  and spreading on dishes coated with 
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exogenous TSP ,  however [29, 31]. In  this study it was found that this antibody reacts 
strongly with squamous carcinoma cells in the viable state. In contrast, two other 
antibodies (e.g. A6.1 and A4.1), which are potent  inhibitors of T S P  induced 
at tachment  and spreading [29, 31], were much  less effective (A6.1) or failed 
completely (A4.1) to stain cells in the viable state. Taken  together, these data suggest 
that the heparin-binding domain of the T S P  molecule (which is known f rom other 
studies to reside in a peripheral  region of the intact molecule [10]) is exposed on 
viable cells. In contrast, the core region of the molecule (recognized by antibodies 
A6.1 and A4.1) may reside in a port ion of the molecule which is relatively unexposed 
on the cell surface. As the antibodies which bind to this region of the molecule (A6.1 
and A4.1) are effective inhibitors of TSP- induced  at tachment  and spreading, this 
may suggest that there is a cell binding domain in this region of the molecule and that 
interaction of this cell binding domain with its binding site on the cell surface 
stimulates adhesion. Alternatively, the T S P  molecule is known to undergo 
conformational  changes which alter its interaction with certain monoclonal anti- 
bodies [7]. The  conformational state of the molecule on the cell surface may be such 
that it is not capable of interacting with ant ibody A4.1. Studies to distinguish 
between these possibilities are in progress. 
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